Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer

Stopped The study was stopped because the research team was unable to enroll any participants

Conditions

• Non-small Cell Lung Cancer

Interventions

• DRUG: Pazopanib plus Paclitaxel

Sponsor

Loyola University

Collaborators

• [object Object]